Bisphenol A (BPA), a ubiquitous endocrine disruptor that is present in many household products, has been linked to obesity, cancer, and, most relevant here, childhood neurological disorders such as anxiety and hyperactivity. However, how BPA exposure translates into these neurodevelopmental disorders remains poorly understood. Here, we used zebrafish to link BPA mechanistically to disease etiology. Strikingly, treatment of embryonic zebrafish with very low-dose BPA (0.0068 μM, 1,000-fold lower than the accepted human daily exposure) and bisphenol S (BPS), a common analog used in BPA-free products, resulted in 180% and 240% increases, respectively, in neuronal birth (neurogenesis) within the hypothalamus, a highly conserved brain region involved in hyperactivity. Furthermore, restricted BPA/BPS exposure specifically during the neurogenic window caused later hyperactive behaviors in zebrafish larvae. Unexpectedly, we show that BPAmediated precocious neurogenesis and the concomitant behavioral phenotype were not dependent on predicted estrogen receptors but relied on androgen receptor-mediated up-regulation of aromatase. Although human epidemiological results are still emerging, an association between high maternal urinary BPA during gestation and hyperactivity and other behavioral disturbances in the child has been suggested. Our studies here provide mechanistic support that the neurogenic period indeed may be a window of vulnerability and uncovers previously unexplored avenues of research into how endocrine disruptors might perturb early brain development. Furthermore, our results show that BPA-free products are not necessarily safer and support the removal of all bisphenols from consumer merchandise.endocrine disruption | androgen receptor | aromatase | hyperactivity I n humans and rodent models, gestational exposure to bisphenol A (BPA) has been associated with increased risk of developing social (e.g., aggression), psychiatric (e.g., depression), and behavioral (e.g., hyperactivity) challenges later in life (1-7). BPA is a compound used in the production of diverse consumer products, ranging from baby bottles to thermal paper used for credit card receipts (8-10). Even though adults can experience adverse health following continued exposure to BPA, the fetal brain is especially vulnerable because of an immature xenobioticmetabolizing system and blood-brain barrier (11,12). Exactly how BPA exposure in utero translates into neurodevelopmental disorders later in life is only beginning to be explored (13-15).Despite a wide body of research illustrating adverse effects of BPA, controversy exists around the true effects of low-dose exposure, as is most often the case in humans. In accordance with standardized toxicological testing procedures, government agencies in the United States (the US Environmental Protection Agency, USEPA), Canada (Health Canada), and Europe (the European Food Safety Authority, EFSA) have established tolerable daily intake levels, ranging from 25-50 μg BPA·kg body weight [16][17][18]. Given th...